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Abstract 21 
Extracts prepared from leaves, roots, and stems of Solanum stramoniifolium Jacq. (Solanaceae) in 22 
80% ethanol have been tested for their in vitro antioxidant, anti-inflammatory, antimicrobial, and 23 
cytotoxic activities in aim to find new sources of substances for functional foods and food 24 
additives. The root extract revealed the highest antioxidant activity in all assays exceeding the 25 
trolox capacity, and was the only extract that inhibited the nitric oxide production in mouse 26 
macrophage cells, showing also the capacity to suppress the growth of all tested human tumor 27 
cell lines (MCF-7, NCI-H460, HeLa and HepG2). The leaf extract showed the strongest 28 
antimicrobial activity inhibiting all tested clinical isolates. To the author’s best knowledge it was 29 
the first time that all individual parts of this plant were tested for biological activity together with 30 
the phenolic compounds characterization. 31 
 32 
Keywords: Antioxidant; Anti-inflammatory; Cytotoxicity; Antimicrobial activity; Phenolic 33 
compounds; Solanum stramoniifolium;  34 
35 
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1. Introduction 36 
Recently, food industry is interested in the application of naturally occurring phytochemical 37 
compounds with biological activity into food products to enhance their nutraceutical value, health 38 
benefits, safety and shelf-life.
1
 Moreover, customers demand for more natural and safer food 39 
additives and the growing number of chronic diseases motivates scientist to search for new 40 
substances that would meet such expectations.
2
 41 
Plants from tropic regions, such as Trinidad and Tobago, grow in a highly competitive 42 
environment and therefore produce large amounts of secondary metabolites for their defense. 43 
These edible and medicinal plants, usually rich in polyphenols, are often a good source of new 44 
bioactive compounds.
3
 Solanum stramoniifolium Jacq. (coco-chat) is a hairy fruited pea-eggplant 45 
of the Solanaceae family with distribution in Asia, South America, Mesoamerica, and Caribbean. 46 
It is a perennial shrub, 1 to 2 meters high and about as broad; its stems, branches as well as leaves 47 
are sparsely prickly. Fruits are 1-2 cm in diameter, globose, hairy, orange or red when ripe.
4
 The 48 
ripe fruits are consumed while leaves and roots are used in traditional medicine to treat thrush, 49 
cold, venereal diseases, inflammations, asthma, arthritis, liver problems, malaria and cancer.
5–8
 50 
In S. stramoniifolium plants originating from Thailand, fruits have been excessively tested, 51 
however other plant parts remain unexplored. The antioxidant activity (DPPH and ABTS tests, 52 
respectively) of water and methanol extracts was described as weak and explained by the low 53 
total phenolic content in the fruits.
9,10
 Methanol and ethyl acetate extracts of fruits inhibited 54 
Gram-negative bacteria Escherichia coli in disc diffusion test, however the same extracts showed 55 
no activity against Salmonella typhimurium, Shigella sonnei, Helicobacter pylori, Streptococcus 56 
pyogenase, Salmonella typhi, Staphylococcus aureus, Streptococcus viridians, and Enterococci 57 
sp.
11
 On the contrary, the water extract of seeds contained small proteins (MW < 14.4 kDa) with 58 
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significant antimicrobial activity against both Gram-positive and Gram-negative bacteria with 59 
Bacillus subtilis, Bacillus licheniformis and Pseudomonas aeruginosa being the most sensitive in 60 
the disc diffusion test, and with no inhibition of E. coli and Klebsiella  pneumoniae.
12
 The 61 
bioactive compounds of this species are, nevertheless, an unexplored field. The ethanolic extract 62 
of roots revealed the presence of alkaloids, flavonoids, tannins, triterpenes and saponins in a 63 
Brazilian study.
13
 The only study on phytochemical compounds of S. stramoniifolium from 64 
Trinidad and Tobago described the isolation of solamargine, a solasodine glycoalkaloid.
14
 65 
According to the World Health Organization, chronic disorders such as cancer, diabetes and 66 
hypertension are becoming the major causes of mortality not only in Trinidad and Tobago, but 67 
also worldwide.
15
 Therefore, it would be desirable to search for new tropical plant sources rich in 68 
bioactive compounds that can be applied either as nutraceuticals or in functional foods to fight 69 
and prevent these diseases. The combination of the health benefits, lately required by consumers, 70 
and the positive role in food safety and storage due to the strong antimicrobial and antioxidant 71 
activity of this plant may be of great interest to the modern food industry in development of new 72 
products.  73 
To the author’s best knowledge, this is the first detailed study of individual parts, such as leaves, 74 
stems and roots of S. stramoniifolium reporting their anti-inflammatory, antimicrobial, 75 
antioxidant, and cytotoxic activities with association to the phenolic compound profiles. 76 
 77 
2. Materials and methods 78 
2.1. Reagents and standards 79 
Acetonitrile 99.9% of HPLC grade was from Fisher Scientific (Lisbon, Portugal). The standards 80 
trolox (6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid), β-carotene and ellipticine were 81 
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purchased from Sigma-Aldrich (St. Louis, MO, USA), as also acetic acid, phosphate buffered 82 
saline (PBS), sulforhodamine B (SRB), and lipopolysaccharide (LPS). Phenolic compound 83 
standards were from Extrasynthèse (Genay, France). DPPH (2,2-diphenyl-1-picrylhydrazyl) was 84 
obtained from Alfa Aesar (Ward Hill, MA, USA). The Griess reagent system was purchased from 85 
Promega Corporation (Madison, WI, USA). The culture media Muller Hinton broth (MHB) and 86 
Tryptic Soy Broth (TSB) were obtained from Biomerieux (Marcy l’Etoile, France). The dye p-87 
iodonitrotetrazolium chloride (INT) was purchased from Sigma-Aldrich (Spruce Street; St. Louis, 88 
MO) and was used as microbial growth indicator. All other chemicals were of analytical purity 89 
and obtained from common suppliers. Water was treated via the purification system Milli-Q 90 
water (TGI Pure Water Systems, Greenville, SC, USA). 91 
2.2. Plant material 92 
Plant material was harvested during May 2015 in Santa Cruz area (Trinidad), after consultation 93 
with local healers. Table 1 presents the botanical name, local names, plant parts investigated and 94 
popular uses of the plant in natural medicine. The samples were authenticated by Dr. Walcott at 95 
the National Herbarium, University of West Indies, St. Augustine Campus, Trinidad and voucher 96 
specimen TRIN 40646 was deposited thereby. 97 
 98 
2.3. Preparation of plant extracts 99 
Leaves, stems and roots were air dried separately right after harvesting and grinded to a fine 100 
powder by using an electric laboratory scale mill (Grindomix, Retsch, Germany). Each sample 101 
(1.5 g) was extracted twice with 30 mL of ethanol/water (80:20, v/v) for 1 hour at 150 rpm and 102 
room temperature. Subsequently, the supernatant was filtered through Whatman No. 4 filter 103 
paper. Ethanol was then evaporated under vacuum at 40 °C (Büchi R-210; Flawil, Switzerland) 104 
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and the water residue was lyophilized (FreeZone 4.5 model 7750031, Labconco, Kansas City, 105 
MO, USA). The resulting fine powder (20 mesh) was mixed to yield homogenized crude extracts 106 
and stored in the dark at room temperature until tested. The methodology routinely used in our 107 
laboratory was modified according to ethnopharmaceutical requirements on solvents.
16
 108 
 109 
2.4. Phenolic compounds profile 110 
A routine method used in our laboratory was followed.
17
 Dry lyophilized extracts were re-111 
dissolved in water/ethanol (80:20, v/v) using a sonic bath, filtered through a 0.22 µm nylon filter 112 
and submitted to HPLC analysis.  113 
Chromatographic data were acquired from Dionex Ultimate 3000 UPLC (Thermo Scientific, San 114 
Jose, CA, USA). This system consists of a diode array detector coupled to an electrospray 115 
ionization mass detector (LC-DAD-ESI/MSn), a quaternary pump, an auto-sampler (kept at 5 116 
ºC), a degasser and an automated thermostatted column section (kept at 35ºC). Waters Spherisorb 117 
S3 ODS-2 C18 (3 µm, 4.6 × 150 mm, Waters, Milford, MA, USA) column provided 118 
chromatographic separations. The solvents used were (A) 0.1% formic acid in water and (B) 119 
acetonitrile. The gradient elution applied was: 15% B (0-5 min), 15% B to 20% B (5-10 min), 20-120 
25% B (10-20 min), 25-35% B (20-30 min), 35-50% B (30-40 min), the column was then re-121 
equilibrated, using a flow rate of 0.5 mL/min. Data were collected simultaneously with a DAD 122 
(280 and 370 nm) and in a mass spectrometer. Negative mode was chosen for MS detection on a 123 
Linear Ion Trap LTQ XL mass spectrometer (ThermoFinnigan, San Jose, CA, USA). Sheath gas 124 
(nitrogen) was kept on 50 psi. Other parameters settings: source temperature 325 °C, spray 125 
voltage 5 kV, capillary voltage -20 V, tube lens offset -66 V, collision energy 35 arbitrary units. 126 
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The full scan captured the mass between m/z 100 and 1500. Xcalibur® data system 127 
(ThermoFinnigan, San Jose, CA, USA) was operating the data acquisition. 128 
For identification of the phenolic compounds, retention times, UV-VIS and mass spectra were 129 
compared with available standards. Data from literature were used to tentatively identify the 130 
remaining compounds. Calibration curves of available phenolic standards were constructed based 131 
on the UV signal to perform quantitative analysis. Identified phenolic compounds with 132 
unavailable commercial standard were quantified via calibration curve of the most similar 133 
standard available. The results were expressed as mg/g of dry extract. 134 
 135 
2.5. Biological activity screening 136 
Antibacterial activity. Clinical isolates from patients hospitalized in the Local Health Unit of 137 
Bragança and Hospital Centre of Trás-os-Montes and Alto-Douro-Vila Real, Northeast of 138 
Portugal were used in the assay. Four Gram-positive bacteria (Enterococcus faecalis isolated 139 
from urine; Listeria monocytogenes isolated from cerebrospinal fluid; MSSA: methicillin-140 
sensitive Staphylococcus aureus isolated from wound exudate and MRSA: methicillin-resistant 141 
Staphylococcus aureus, isolated from expectoration), and six Gram-negative bacteria 142 
(Acinetobacter baumannii and Pseudomonas aeruginosa isolated from expectoration; 143 
Escherichia coli, Escherichia coli spectrum extended producer of β-lactamases (ESBL); 144 
Klebsiella pneumoniae, Klebsiella pneumoniae ESBL, all isolated from urine); were used to 145 
screen the antibacterial activity of the extracts. Microorganism identification and susceptibility 146 
tests were performed on the MicroScan panels (MicroScan®; Siemens Medical Solutions 147 
Diagnostics, West Sacramento, CA, USA) using the microdilution method. The interpretation 148 
criteria were based on Interpretive Breakpoints as indicated in Clinical and Laboratory Standards 149 
Institute 
18
 and in the European Committee on Antimicrobial Susceptibility Testing.
19
 150 
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Microdilution method with rapid p-iodonitrotetrazolium chloride (INT) colorimetric assay 151 
according to Kuete et al.
20
 with some modifications was performed. The extract was diluted in 152 
appropriate media according to bacteria requirements and successive dilutions were carried out in 153 
the wells (20 to 0.156 mg/mL of final concentration). Three negative controls (MHB/TSB, the 154 
extract, and medium with antibiotic) and a positive control (MHB and each inoculum) were 155 
prepared. For the Gram-negative bacteria, negative control antibiotics, such as amikacin (K. 156 
pneumoniae ESBL and P. aeruginosa), tobramycin (A. baumannii), amoxicillin/clavulanic acid 157 
(E. coli and K. pneumoniae) and gentamicin (E. coli ESBL) were used. The concentration used 158 
was based on the MIC obtained (Table 2). For the Gram-positive bacteria, ampicillin (L. 159 
monocytogenes) and vancomycin (MSSA, MRSA and E. faecalis) were used (Table 3). 160 
MIC was defined as the lowest extract concentration that prevented the color change (from 161 
yellow dye to dark pink), caused by the viable microorganisms, and exhibited the complete 162 
inhibition of bacterial growth. 163 
Antioxidant activity. Hydroethanolic extracts were re-dissolved in ethanol/water (80:20, v/v) to 164 
the final concentration 20 mg/mL and further diluted to 0.156 mg/mL to be submitted to the 165 
following assays. The antioxidant activity was evaluated by DPPH radical-scavenging activity, 166 
reducing power, inhibition of β-carotene bleaching in the presence of linoleic acid radicals and 167 
inhibition of lipid peroxidation using TBARS in brain homogenates.
21
 The extract concentrations 168 
providing 50% of antioxidant activity or 0.5 of absorbance (EC50) were calculated from the 169 
graphs of antioxidant activity percentages (DPPH, β-carotene bleaching and TBARS assays) or 170 
absorbance at 690 nm (reducing power assay) against extract concentrations. Trolox was used as 171 
positive control. 172 
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Anti-inflammatory activity. Method previously described by Correa et al.
22
 was performed in 173 
concentration range 400 – 125 µg/mL. Dexamethasone (50 µM) was used as a positive control. 174 
The mouse macrophage-like cell line RAW 264.7 stimulated with LPS was used in the assay. 175 
Nitric oxide (NO) production was studied with Griess Reagent System kit. Results were 176 
expressed as EC50 values (µg/mL) equal to the sample concentration providing a 50% inhibition 177 
of NO production.  178 
Cytotoxicity. Dry extracts (stock concentration 8 mg/mL, re-dissolved in water) were further 179 
diluted to different concentrations to be submitted to in vitro antitumor activity and 180 
hepatotoxicity evaluation at final well concentrations (400 – 1.5 µg/mL). The cytotoxicity was 181 
determined using four human tumour cell lines, HeLa (cervical carcinoma), HepG2 182 
(hepatocellular carcinoma), MCF-7 (breast adenocarcinoma) and NCI-H460 (non-small cell lung 183 
cancer), following a procedure already descried by the authors.
17
 The cell growth inhibition was 184 
measured using sulforhodamine B assay, were the amount of pigmented cells is directly 185 
proportional to the total protein mass and therefore to the number of bounded cells. 186 
For hepatotoxicity evaluation, a freshly harvested porcine liver, obtained from a local slaughter 187 
house, was used in order to obtain the cell culture, designated as PLP2. The growth inhibition 188 
was evaluated using the SRB assay, as previously described.
23
 The results were expressed in GI50 189 
values; sample concentration that inhibited 50% of the net cell growth. Ellipticine was used as 190 
positive control. 191 
 192 
2.6. Statistical analysis 193 
Three repetitions (or two repetitions in case of antimicrobial assay) of the samples were used and 194 
triplicates for each concentration reading were carried out in all the assays. Results are expressed 195 
as mean values and standard deviations (SD). The results were analyzed using one-way analysis 196 
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of variance (ANOVA) followed by Tukey’s HSD test with p = 0.05. When necessary, a Student´s 197 
t-test was used to determine the significant difference among two different samples, with p = 198 
0.05. Both statistical treatments were carried out using SPSS v. 23.0 program.  199 
 200 
3. Results and discussion 201 
3.1 Phenolic compounds profile 202 
Tables 4A and 4B present chromatographic data and tentative determination of phenolic 203 
compounds in the hydroethanolic extracts of leaves, stems, and roots of Solanum stramoniifolium 204 
Jacq. In leaves, 6 phenolic acid derivatives and 14 flavonoids (flavonol glycoside derivatives) 205 
were confirmed. Compounds 2 and 6 were positively identified as protocatechuic acid and 5-O-206 
caffeoylquinic acid (chlorogenic acid) after comparing the obtained LC-MS data with those of 207 
commercial standards. Compound 5 was tentatively assigned as the corresponding cis isomer of 208 
5-O-caffeoylquinic acid based on its fragmentation pattern and lower levels compared with peak 209 
6. Furthermore, cis hydroxycinnamoyl derivatives would be expected to elute before the 210 
corresponding trans ones, as observed after UV irradiation (366 nm, 24 h) of hydroxycinnamic 211 
acids in our laboratory.
24
 Cis and trans isomers of 4-O-caffeoylquinic acid (compounds 3 and 4) 212 
and trans 3-O-caffeoylquinic acid  (compound 1) were distinguished and identified by typical 213 
fragmentation patterns as described by Clifford et al.
25,26
 To the best of our knowledge these 214 
compounds were described in Solanum stramoniifolium Jacq. for the first time.  215 
The flavonol derivatives detected in the leaf extract were mainly glycosides of quercetin (λmax 216 
around 354 nm; MS
2 
fragment m/z 301), isorhamnetin (λmax around 356 nm; MS
2 
fragment m/z 217 
317), and kaempferol (λmax around 348 nm, MS
2 
fragment m/z 285). 218 
Quercetin-3-O-rutinoside (rutin; compound 10), kaempferol-3-O-rutinoside (nicotiflorin; 219 
compound 14), isorhamnetin-3-O-rutinoside (narcissin; compound 16), kaempferol-3-O-220 
Page 10 of 29Food & Function
Fo
od
&
Fu
nc
tio
n
A
cc
ep
te
d
M
an
us
cr
ip
t
Pu
bl
ish
ed
 o
n 
21
 A
pr
il 
20
17
. D
ow
nl
oa
de
d 
by
 M
id
dl
e 
Ea
st 
Te
ch
ni
ca
l U
ni
ve
rs
ity
 (O
rta
 D
og
u T
ek
nik
 U
) o
n 2
1/0
4/2
01
7 1
0:5
8:1
3. 
View Article Online
DOI: 10.1039/C7FO00297A
  
11
glucoside (astragalin; compound 17) and isorhamnetin-3-O-glucoside (compound 18) were 221 
positively identified upon comparison of their retention times, UV-Vis characteristics and mass 222 
spectra with available commercial standards. 223 
Compound 7 presented a pseudomolecular ion [M-H]
-
 at m/z 625, releasing a MS
2
 fragment at 224 
m/z 301 ([M-H-162-162]
−
, loss of two hexosyl moieties), which led to its tentative identification 225 
as quercetin-O-dihexoside. Compounds 8, 11, and 13 provided the same fragmentation losses of 226 
deoxyhexose (146 u) and deoxyhexosyl-hexose (308 u), indicating location of each residue on 227 
different positions of the aglycons of quercetin, kaempferol, and isorhamnetin ([M-H]
-
 at m/z 228 
755, 739, and 769, respectively). Similarly, MS
2
 fragments of peaks 9 and 12 revealed the 229 
alternative loss of hexosyl (m/z at 593; -162 u) and deoxyhexosyl-hexose (m/z at 285; -308 u) 230 
residues. The positive identification of present rutinosides, including quercetin-3-O-rutinoside, in 231 
the samples may suggest a rutinoside identity for the deoxyhexosyl-hexose residues in peaks 8, 9, 232 
11 and 13.  However, in case of peak 12, the information about the identity of the sugar moieties 233 
and location onto the aglycon could not be confirmed, therefore the compound was tentatively 234 
identified as kaempferol-O-hexosyl-O-deoxyhexosyl-hexoside. Compound 15 ([M-H]
-
 at m/z 235 
623) presented the same pseudomolecular ion as compound 16, but showed an earlier retention 236 
time. The observation of just a single MS
2
 fragment (m/z at 315; - 308 u), could indicate that the 237 
two sugar units were linked together and the compound was tentatively assigned as isorhamnetin-238 
O-deoxyhexosyl-hexoside. 239 
Compounds 19 ([M-H]
-
 at m/z 771) and 20 ([M-H]
-
 at m/z 755) could correspond to compounds 240 
including an acylation with a phenolic acid. The observation in their fragmentation of a product 241 
ion at m/z 609 and 593, respectively, from the losses of caffeoyl residue (162 u), could also be 242 
coherent with that identity, as well as the late elution, since the presence of the 243 
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hydroxycinnamoyl residue implies a decrease in polarity. Therefore, these molecules were 244 
tentatively assigned to quercetin-O-caffeoyl-rutinoside and kaempferol-O-caffeoyl-rutinoside. 245 
The root and stem extracts gave a similar phenolic profile, obtaining different quantity of seven 246 
identified compounds. Compounds 5 and 6 were identified as 5-O-caffeoylquinic isomers cis- 247 
and trans- as described above. The root extract gave higher amounts of these substances than the 248 
stem extract. Compounds 21, 24, and 25 ([M-H]
-
 at m/z 472) were thought to represent polyamine 249 
derivatives, namely three isomers of N,Nʹ-bis(dihydrocaffeoyl)spermidine as described in 250 
literature by Parr et al.
27
 Similarly, and taking into account the findings reported by Gancel et 251 
al.
28
, compound 23 ([M-H]
-
 at m/z 637) lead to N,Nʹ,Nʺ-tris(dihydrocaffeoyl)spermidine and its 252 
hexoside, compound 22; [M-H]
-
 at m/z 799, which gives a MS
2
 fragment at m/z 637 [M-H-162]
-
. 253 
Nevertheless, a complete identification of the position of dihydrocaffeoyl groups on spermidine 254 
skeleton was not possible. Compound 23 was the most abundant compound present in both parts 255 
of this species. 256 
Flavonoids were the most abundant group of phenolic compounds identified in the present study. 257 
Nevertheless, polyamine derivatives (spermidines) were dominant in the root and stem extracts. 258 
Up to date, no record exists on spermidine derivatives in S. stramoniifolium, however, their 259 
presence was frequently described in other representatives of Solanum genus, such as potato (S. 260 
tuberosum) or naranjilla fruit (S. quitoense).
28,29
 261 
 262 
3.2. Biological activity 263 
The increasing number of bacterial strains resistant to severe available antibiotics remains a huge 264 
problem and is a driving force for search of new compounds with antimicrobial activity.
30
 265 
Furthermore, the food industry calls for natural antimicrobial additives that would be efficient 266 
and safe for human consumption at the same time. Various natural peptides, polysaccharides, 267 
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terpenes, and phenolic compounds have been applied as food preservatives with no toxicity, such 268 
as thymol, carvacrol, chitosan, and nisin.
31
 269 
The crude extracts of leaves, stems, and roots of S. stramoniifolium were tested for antimicrobial 270 
activity against selected clinical isolates representing both Gram-positive and Gram-negative 271 
bacteria: Acinetobacter baumannii, Klebsiella pneumoniae, Pseudomonas aeruginosa and 272 
Staphylococcus aureus, all known to exhibit multi-resistance to antibiotics and labeled as the 273 
ESKAPE pathogens (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, 274 
Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species).
32
 It is 275 
established that the Gram-negative bacteria possess stronger resistance due to their protective 276 
outer membrane rich in lipopolysaccharides
33
, which is missing in Gram-positive bacteria.  277 
In Table 5, the results obtained from broth microdilution method with INT colorimetric 278 
evaluation are displayed. As it can be seen, all three extracts exhibited antimicrobial activity to all 279 
the assayed bacteria, and MICs ranged from 2.5 to 20 mg/mL. In two cases, the MIC was above 280 
the maximal tested concentration (stem extract against A. baumannii and P. aeruginosa). In 281 
general, the Gram-positive bacteria were more sensitive to the extracts than Gram-negative 282 
bacteria, as expected. However, the root extract presented non-selective inhibition providing the 283 
same MIC values for 9 of 10 bacterial strains (10 mg/mL). On the other hand, the stem extract 284 
was significantly more active against Gram-positive bacteria. Listeria monocytogenes was the 285 
most susceptible organism providing the lowest MICs in stem extract (2.5 mg/mL). P. 286 
aeruginosa was the least inhibited organism in the assay. Overall, the leaf extract was the most 287 
effective inhibitor with MICs of 5 mg/mL obtained for 7 clinical isolates. Notably, the bacteria 288 
with special characteristic, such as methicillin-resistant MRSA or β-lactamase producing E. coli 289 
and K. pneumoniae, did not present higher MICs than their more sensitive analogues. The water 290 
extract of seeds from S. stramoniifolium (Thailand) showed significant multispectral inhibition 291 
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(S. aureus, P. aeruginosa, Bacillus. subtilis, Bacillus licheniformis, Xanthomonas sp., Salmonella 292 
typhi), however inhibition of E.coli and K. pneumoniae were not observed in the disc diffusion 293 
test.
12
 294 
From the phenolic compounds identified in the plant parts, nicotiflorin, rutin, and chlorogenic 295 
acid were previously related with antimicrobial activity in the Solanum genus 
34
 and therefore can 296 
contribute to the inhibitory potential of this species. 297 
The results of antioxidant, anti-inflammatory and cytotoxic activity are included in Table 6, due 298 
to their possible relationship previously described in literature.
35,36
 Polyphenol extracts have been 299 
used in food industry as they often exert multiple biological activities in protection against 300 
spoilage and oxidation via synergism of the compounds they contain.
31
 301 
The antioxidant activity was evaluated using four in vitro assays covering various mechanisms, 302 
such as hydrogen atom transfer (HAT) and single electron transfer (SET), to fully unfold the 303 
antioxidant capacity of studied samples.
37
 304 
As it can be observed in Table 6, all plant parts extracts showed significant antioxidant potential 305 
in the four assays (DPPH; reducing power, β-carotene bleaching inhibition and TBARS). The 306 
root extract stands out when compared to the other plant parts. It was significantly more effective 307 
than trolox standard in all antioxidant assays, providing lower EC50 values in each of the tested 308 
assays. Regarding DPPH scavenging capacity assay, the plant parts were declining as follows: 309 
root > leaf > stem with corresponding EC50 values of 13 ± 1; 50 ± 2 and 74 ± 4 µg/mL, 310 
respectively. In reducing power assay, two extracts provided better results than the standard 311 
trolox (EC50 = 41.7 ± 0.3 µg/mL), namely root and leaf (EC50 of 8.68 ± 0.03 and 23.7 ± 0.1 312 
µg/mL, respectively). The order of activity in reducing power was: root > leaf > stem, as 313 
observed in DPPH assay as well. Moreover, the same two extracts proved to be better β-carotene 314 
bleaching inhibitors than trolox, as only the stem extract gave a higher EC50 value than this 315 
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standard (23.4 ± 0.4 versus 18 ± 1 µg/mL). In TBARS inhibition test, only the root extract 316 
exceeded trolox capacity, however the results were still quite promising (root > leaf > stem; EC50 317 
values corresponding to 15 ± 1; 33 ± 1 and 60 ± 1 µg/mL, respectively). Previously, 318 
Wetwitayaklung and Phaechamud
10
 observed low scavenging activity for methanol fruit extract 319 
of S. stramoniifolium in TEAC assay using ABTS˙
+
 radical (IC50 = 1133.08 µg comparing to 320 
10.14 µg for trolox) and correlated it to the low presence of total phenolic compounds (1.55 g 321 
gallic acid equivalents/100 g extract).  322 
Lipid peroxidation products (f. e. malondialdehyde), as well as free radicals, may damage 323 
important cell macromolecules, such as DNA, proteins, and lipids and contribute to the 324 
development of pathological processes, including aging, cancer, atherosclerosis, coronary heart 325 
disease or neurodegenerative problems.
38
 Despite the effectiveness of endogenous antioxidant 326 
systems, an exogenous source of antioxidants is necessary in case of excessive presence of 327 
oxidative species. Therefore, prevention or limitation of oxidative stress might be achieved by 328 
dietary antioxidants, such as phenolic-rich plant extracts. 329 
From the tested plant parts, only root revealed activity in the NO production (EC50 = 100 ± 6 330 
µg/mL) as stated in Table 6. Leaf and stem did not show any activity within the maximal 331 
concentration tested (400 µg/mL), which is surprising according to the traditional choice of 332 
leaves for external inflammations. It can be suggested that other than NO production-related 333 
mechanisms are involved and different assays shall be evaluated in future to study this activity. 334 
More than 60% of agents used in cancer therapy are from natural sources, especially tropical 335 
plants.
39
 The Solanum genus is a good source for anticancer substances, such as solanine or 336 
solamargine.
40,41
 The antitumor potential was evaluated against four human tumor cell lines 337 
represented by MCF-7 (breast carcinoma), NCI-H460 (non-small cell lung cancer), HeLa 338 
(cervical carcinoma) and HepG2 (hepatocellular carcinoma), and porcine liver primary culture 339 
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PLP2 was selected for cytotoxicity assessment against non-tumor cells. Observing the results 340 
presented in Table 6, it can be concluded that leaf and root are the most promising plant parts 341 
with antitumor compounds as they inhibited all tumor cell lines used in the study. The highest 342 
inhibition was found for HepG2, yielding the lowest GI50 (40 ± 3 µg/mL for root and 85 ± 6 343 
µg/mL for leaf extract). The stem extract was efficient only in MCF-7 cell line inhibition (GI50 = 344 
242 ± 4 µg/mL). The most sensitive cell line was MCF-7, which was inhibited by all three 345 
extracts in the following order root > leaf > stem. Interestingly, the root extract provided lower 346 
GI50 for HepG2, MCF-7 and NCI-H460 than leaf, but was less effective against HeLa cell line. 347 
Comparing to ellipticine, the extracts revealed medium activity. Nevertheless, ellipticine has a 348 
very strong inhibiting power on all presented tumor cell lines, but also exhibits high 349 
hepatotoxicity to non-tumor PLP2 cell line. In our case, only root showed mild hepatotoxicity 350 
towards PLP2 (GI50 = 252 ± 10 µg/mL), however it did not exceed active concentrations against 351 
the tumor cell lines (40 ± 3 µg/mL in HepG2; 52 ± 5 µg/mL in MCF-7; 113 ± 5 µg/mL in NCI-352 
H460; and 206 ± 15 µg/mL in HeLa). 353 
Consequently, although the leaf and root extracts of S. stramoniifolium could be useful in the 354 
development of new anticancer products, the leaf is the most promising part, since it did not 355 
present unspecific toxicity, as suggested by results obtained with PLP2 assay. 356 
Due to the possible synergic effect of present compounds, the plant crude extracts can often be a 357 
more powerful antioxidant tool than individual substances. Moreover, the natural matrices in 358 
form of crude extracts possess usually very low toxicity comparing to individual chemicals and 359 
therefore are currently experiencing a renaissance in both phytopharmacological and food 360 
industry.
31
 361 
 362 
4. Conclusions 363 
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This study highlights the potential of different parts of Solanum stramoniifolium Jacq. as a rich 364 
source of biologically active compounds suitable for the application in food industry, for example 365 
in the development of novel functional foods and nutraceutical formulations. Ethanol/water 366 
extracts from leaves, stems, and roots demonstrated to have a strong biological activity. The root 367 
extract gave the highest antioxidant potential exceeding trolox standard values. It also 368 
significantly inhibited the growth of MCF-7 and HepG2 tumor cell lines. The leaf extract showed 369 
the best results in the antimicrobial assay inhibiting all the clinical bacterial isolates. 370 
Furthermore, it did not possess any cytotoxicity, unlike the root extract, and therefore might be a 371 
better candidate for the food industry. The phenolic compounds in the extracts revealed the 372 
content of compounds known for their biological activities, such as caffeoylquinic acid 373 
derivatives, flavonoids and polyamines. The presence of these compounds could be correlated 374 
with the high biological activity shown by these extracts. Several compounds were determined 375 
for the first time in this plant. 376 
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Table 1. Ethnomedicinal information on Solanum stramoniifolium Jacq. 
Family Synonyms Vernacular names Ethnomedicinal use 
Solanaceae 
Solanum demerarense Dunal  
Solanum hirsutum Herb. Peurari ex Dunal  
Solanum maccai Dunal  
Solanum platyphyllum Dunal  
Solanum stramonifolium Jacq.,  
Solanum toxicarium Lam.  
Solanum toxicarum Rich.  
Solanum trichocarpum Miq.  
Solanum undecimangulare Willd. ex Roem. & Schult.27 
Trinidad: coco-chat Brazil: jóa, 
jurubeba 
Colombia: e-to-pa-a, kobu-yá, 
uvilla  
Guyana: bura bura  
Peru: shiwánkush, coconilla
27
 
India: ram begun, tide begal
5
 
Root: toothache, venereal diseases, 
malaria, fever, cancer
6
 
Leaves: thrush, cold, sores
6
 
Fruits: sores, irritations, ant bites
6
 
Whole plant: chest pain, asthma
5
,liver 
problems
7
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Table 2. Resistance profile of Gram-negative bacteria to different antibiotics; MIC values (µg/ml). 
Antibiotics A. baumannii E. coli E. coli ESBL K. pneumoniae  K. pneumoniae ESBL P. aeruginosa 
Ampicilin na  >8 R na   >8 R ≥32 R na  
Amoxicillin/Clavulanic Acid na  ≤8/4 S na   ≤8/4 S ≥32 R na  
Amikacin na    na 16 I na   ≤2 S ≤8 S 
Cefuroxim na  ≤4 S na   >8 R ≥64 R na  
Cefotaxim >32 R ≤1 S na   >2 R ≥64 R na  
Ceftazidim 16   I ≤1 S ≥64 R na   16 R >8 R 
Norfloxacin na  >8 R na   >1 R na   na  
Levofloxacin na    na na   na   ≥8 R >2 R 
Ciprofloxacin >2 R >1 R 0.5 S >1 R ≥4 R >1 R 
Nitrofurantoin na  ≤32 S na   >64 R 256 R na  
Fosfomycin na  ≤16 S na   ≤32 S na   na  
Colistin na    na ≤0.5 S na   na   ≤4 S 
Gentamicin 4 R >4 R ≤1 S ≤2 S ≥16 R > 4 R 
Imipenem na   na 0.5 S na   na   >8 R 
Meropenem na    na ≤0.25 S na   ≤0.25  >8 R 
Piperacillin/Tazobactam na   na ≤4 I ≤8 S ≥128 R >16 R 
Trimethoprim/Sulfamethoxazol na  >4/76 R ≤20 S >4/76 R ≥320 R na  
Tobramycin ≤2 S  na ≥16 R na   ≥16 R > 4 R 
S - Susceptible; I - Intermediate; R - Resistant: classification according to the interpretative breakpoints suggested by Clinical and Laboratory Standards Institute (CLSI) and 
European Committee on Antimicrobial Susceptibility Testing (EUCAST); na - not applicable
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Table 3. Resistance profile of Gram-positive bacteria to different antibiotics; MIC values (µg/ml).  
Antibiotics  MRSA MSSA E. faecalis L. monocytogenes 
Penicillin  >8 R  ≤0.12 S na  na  
Ampicillin  na 
 
 na  ≤4 S ≤0.2 S 
Oxacillin  >0.25 R  ≤0.25 S na  na  
Clindamycin  na 
 
 >0.5 R na  na  
Erythromycin  na 
 
 >2 R na  na  
Ceftarolin  ≤1 S  na  na  na  
Gentamicin  na 
 
 ≤1 S na  na  
Ciprofloxacin  na 
 
 >1 R na  na  
Levofloxacin  na 
 
 >2 R na  na  
Nitrofurantoin  na   na  ≤64 S na  
Linezolid  ≤4 S  na  na  na  
Trimethoprim/Sulfamethoxazol  na 
 
 ≤2/38 S na  ≤2/38 S 
Vancomycin  ≤2 S  ≤2 S ≤2 S na  
MSSA - methicillin-sensitive Staphylococcus aureus; MRSA - methicillin-resistant Staphylococcus aureus;  
S - Susceptible; I - Intermediate; R - Resistant: classification according to the interpretative breakpoints suggested by Clinical and Laboratory Standards Institute 
(CLSI) and European Committee on Antimicrobial Susceptibility Testing (EUCAST); na - not applicable. 
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Table 4A. Retention time (Rt), wavelengths of maximum absorption in the visible region (λmax ), mass spectral data, and tentative 
identification of phenolic compounds in the hydroethanolic extract of Solanum stramoniifolium leaves. 
Compound Rt 
(min) 
λmax  
(nm) 
Molecular 
ion  
[M–H]
-
 
(m/z) 
MS
2
 (m/z) Tentative identificaion Quantification 
(mg/g dry extract) 
1 5.1 328 353 191(100),179(45),172(4),135(56) 3-O-Caffeoylquinic acid 6.49±0.05 
2 5.7 262,292sh 153 119(100) Protocatechuic acid 0.37±0.09 
3 6.7 328 353 191(20),179(19),173(40),135(27) cis-4-O-Caffeoylquinic acid 1.73±0.13 
4 7.2 328 353 191(24),179(28),173(60),134(48) trans-4-O-Caffeoylquinic acid 2.59±0.23 
5 7.5 328 353 191(100),179(12),161(5),135(20) cis-5-O-Caffeoylquinic acid 2.21±0.02 
6 8.0 328 353 191(100),179(52),161(5),135(34) trans-5-O-Caffeoylquinic acid 3.66±0.05 
7 15.2 358 625 463(5),301(100) Quercetin-O-dihexoside 0.11±0.01 
8 15.8 352 755 609(33),301(100) Quercetin-O-deoxyhexosyl-O-rutinoside 2.49±0.01 
9 16.6 350 755 593(100),285(38) Kaempferol-O-hexosyl-O-rutinoside 1.67±0.01 
10 17.2 354 609 301(100) Quercetin-3-O-rutinoside 0.707±0.004 
11 17.6 350 739 593(36),285(95) Kaempferol-O-deoxyhexosyl-O-rutinoside 4.7±0.1 
12 17.9 346 755 593(100),469(50),285(72) Kaempferol-O-hexosyl-O-deoxyhexosyl-hexoside 3.0±0.1 
13 18.3 356 769 623(40),315(100) Isorhamnetin-O-deoxyhexoside-O-rutinoside 1.57±0.01 
14 19.6 350 593 285(100) Kaempferol-3-O-rutinoside 1.8±0.1 
15 20.6 354 623 315(100) Isorhamnetin-O-deoxyhexosyl-hexoside 1.31±0.05 
16 23.9 356 623 315(100) Isorhamnetin-3-O-rutinoside 0.366±0.007 
17 24.7 350 447 285(100) Kaempferol-3-O-glucoside 0.45±0.03 
18 25.4 354 477 315(100) Isorhamnetin-3-O-glucoside 1.5±0.1 
19 26.3 300sh,334 771 609(51),301(44) Quercetin-O-caffeoyl-rutinoside 0.78±0.02 
20 28.3 296sh,332 755 593(9),285(61) Kaempferol-O-caffeoyl-rutinoside 1.5±0.1 
     Total phenolic acids 17.1±0.5 
     Total flavonoids 22.0±0.3 
     Total phenolic compounds 39.1±0.7 
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Table 4B. Retention time (Rt), wavelengths of maximum absorption in the visible region (λmax ), mass spectral data, and tentative 
identification of phenolic compounds in the hydroethanolic extract of Solanum stramoniifolium roots and stems. 
Compound 
Rt 
(min) 
λmax  
(nm) 
Molecular 
ion  
[M–H]
-
 
(m/z) 
MS
2
 (m/z) Tentative identification 
Quantification  
(mg/g dry extract) Student´s 
t-test 
Roots Stems 
5 7.3 328 353 191(100),179(12),161(5),135(20) cis-5-O-Caffeoylquinic acid 2.62±0.22 1.26±0.01 <0.001 
6 7.9 328 353 191(100),179(52),161(5),135(34) trans-5-O-Caffeoylquinic acid 5.03±0.14 3.42±0.02 <0.001 
21 17.4 236,296,320sh 472 350(40),308(31)  Bis(dihydrocaffeoyl) spermidine 
isomer 1 
1.86±0.16 0.43±0.01 <0.001 
22 20.3 226,294,322sh 799 637(100),515(6),472(10),350(3),308(3) Tris(dihydrocaffeoyl) spermidine 
hexoside 
0.63±0.10 1.17±0.01 <0.001 
23 24.3 284 637 515(23),472(47),350(15),308(8) Tris(dihydrocaffeoyl) spermidine  9.51±0.08 1.06±0.02 <0.001 
24 29.4 226,284,316sh 472 350(32),308(38)  Bis(dihydrocaffeoyl) spermidine 
isomer 2 
0.78±0.02 0.46±0.05 <0.001 
25 31.1 226,292,320sh 472 350(30),308(48)  Bis(dihydrocaffeoyl) spermidine 
isomer 3 
0.55±0.09 1.08±0.05 <0.001 
     Total phenolic compounds and 
derivatives 
20.98±0.81 8.89±0.01 <0.001 
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Table 5. Antibacterial activity of Solanum stramoniifolium hydroethanolic extracts (MIC; mg/mL). 
Bacteria 
MIC (mg/mL) 
Leaf Root Stem 
Gram-positive strains    
MRSA 5 10 5 
MSSA 5 10 5 
Enterococcus faecalis 5 10 10 
Listeria monocytogenes 20 10 2.5 
Gram-negative strains    
Acinetobacter baumannii 10 10 >20 
Escherichia coli  5 10 20 
Escherichia coli ESBL 5 10 20 
Klebsiella pneumoniae 5 10 20 
Klebsiella pneumoniae ESBL 5 10 20 
Pseudomonas aeruginosa 10 20 >20 
ESBL = spectrum extended producer of β-lactamases 
MIC = minimal inhibition concentration  
MRSA = methicillin-resistant Staphylococcus aureus 
MSSA = methicillin-sensitive Staphylococcus aureus 
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Table 6. Biological activity of hydroethanolic extracts from different parts of Solanum stramoniifolium Jacq. 
Antioxidant activity (EC50 values, µg/mL)     
 Leaf Root Stem Trolox 
DPPH scavenging activity 50±2b 13±1d 74±4a 41±1c 
β-carotene bleaching inhibition 11.7±0.1c 9.4±0.5d 24.3±0.4a 18±1b 
Reducing power 23.7±0.1c 8.68±0.03d 45±0.3a 41.7±0.3b 
TBARS inhibition 33±1b 15±1d 60±1a 23±1c 
Anti-inflammatory activity (EC50 values, µg/mL) 
 Leaf Root Stem Dexamethasone 
Nitric oxide (NO) production >400 100±6 >400 16±1 
Cytotoxicity to tumor cell lines (GI50 values, µg/mL) 
 Leaf Root Stem Ellipticine 
HeLa (cervical carcinoma) 97±4b 206±15a >400 1.91±0.06c 
HepG2 (hepatocellular carcinoma) 85±6a 40±3b >400 1.1±0.2c 
MCF-7 (breast carcinoma) 206±10b 52±5c 242±4a 0.91±0.04d 
NCI-H460 (non-small cell lung cancer) 155±13a 113±5b >400 1.0±0.1c 
Cytotoxicity to non-tumor cell lines (GI50 values, µg/mL) 
PLP2 (porcine liver primary culture) >400 252±10 >400 3.2±0.7 
Trolox, dexamethasone and ellipticine, respectively, were used as positive controls in the assays. All values are means ± SD (n = 9) and in 
each row different letters represent significant differences (p < 0.05).  
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